Whilst the rate of TP53 pathway abnormalities in BIA-ALCL is not known, the observation of two patients with germline TP53 mutations and recurrent deletion in RPL5 is supportive evidence of the biological importance of an aberrant TP53 pathway in BIA-ALCL. The gene discussed is RPL5; the disease is anaplastic large cell lymphoma.